“Comparison of efficacy of intralesional meglumine antimoniate vs. combination of 50% trichloroacetic acid and intralesional meglumine antimoniate in patients of cutaneous leishmaniasis”, J Pak Assoc Dermatol, vol. 28, no. 4, pp. 426–430, Feb. 2019, doi: 10.66344/jpad.v28i4.1190.